EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics

Clinical trial NCT05979545 · RECRUITING

Trial details

NCT number: NCT05979545
Sponsor: National University of Singapore
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Blood Stream Infections Ventilator Associated Pneumonia Healthcare Associated Infection Carbapenem-Resistant Enterobacteriaceae Infection Hospital-acquired Pneumonia

Start date: 2023-12-12
Primary completion: 2026-10-31
Enrollment: 1900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.